Platelet‐rich fibrin matrix as treatment for complex anal fistulae: A 3‐year experience at a tertiary centre
Colorectal Disease · 2026
DOI: 10.1111/codi.70447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2026. Verfasst von Alejandro Lusilla Lopez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Skåne University Hospital, Malmö, Sweden. Hauptthemen laut MEDLINE: Rectal Fistula, Platelet-Rich Fibrin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Skåne.
Abstract (Originalsprache)
Aim
Treatment of complex anal fistulae remains a significant challenge for physicians and patients. A sphincter‐preserving technique with bioactive platelet‐rich fibrin matrix is one option. This three‐year study aimed to evaluate the efficacy of bioactive platelet‐rich fibrin matrix in treating complex anal fistulae.
Method
This retrospective study analysed data from 2019 to 2022 of patients diagnosed with complex anal fistulae treated with a platelet‐rich fibrin matrix at a tertiary centre. Endoanal ultrasound was used to morphologically characterize fistulas using Park's classification. Pearson's chi‐squared and Kaplan–Meier (log‐rank) analyses were used to evaluate between‐group differences.
Results
A total of 213 patients were included in the study (181 with cryptoglandular fistulae and 32 with Crohn's disease‐associated fistulae) with a median follow‐up of 6.6 months (range 0.5–67.1 months). Cavities and secondary tracts were identified in 14.6% and 34.7% of the patients, respectively. External opening closure occurred in 32% after one procedure and 43% cumulatively after a second intervention. Healing rates did not differ statistically by aetiology or fistula location. Cavities and secondary tracts were associated with failure. During follow‐up, 23% of the secondary tracts healed, whereas cavities derived no significant benefit from the intervention. No serious complications were reported.
Conclusion
Platelet‐rich fibrin matrix is a simple and safe sphincter‐preserving technique that achieves reasonably good results in the treatment of cryptoglandular and Crohn's disease‐associated fistulae. While secondary tracts may respond well, further research is required to optimize the management of fistulae associated with cavities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Skåne University Hospital, Malmö, Sweden.
- Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden.
- Department of Gastroenterology, Skåne University Hospital, Malmö, Sweden.
ORCID-Profile: Alejandro Lusilla Lopez, Ursula Aho Fält, Pamela Buchwald, Olof Grip
Förderung
- Region Skåne
Zitieren
APA
Lusilla Lopez, A., Fält, U. A., Buchwald, P., Johnson, L. B., & Grip, O. (2026). Platelet‐rich fibrin matrix as treatment for complex anal fistulae: A 3‐year experience at a tertiary centre. Colorectal Disease. https://doi.org/10.1111/codi.70447
Vancouver
Lusilla Lopez A, Fält UA, Buchwald P, Johnson LB, Grip O. Platelet‐rich fibrin matrix as treatment for complex anal fistulae: A 3‐year experience at a tertiary centre. Colorectal Disease. 2026. doi:10.1111/codi.70447
BibTeX
@article{LusillaLopez2026,
author = {Lusilla Lopez, Alejandro and Fält, Ursula Aho and Buchwald, Pamela and Johnson, Louis Banka and Grip, Olof},
title = {Platelet‐rich fibrin matrix as treatment for complex anal fistulae: A 3‐year experience at a tertiary centre},
journal = {Colorectal Disease},
year = {2026},
doi = {10.1111/codi.70447}
}
EUVIMED